Products
Host Cell Residue Detection
Process Impurity Assay
Advnetitious Agent/Microorganism Testing
Pyrogen / Endotoxin Detection
Genetic Stability
Cell Line Characterization
Viral Titer Assay
Detection Equipment
Biochemical Reagents
On July 26, 2024, the USP Microbiology Expert Committee officially announced the inclusion of Chapter <86> Bacterial Endotoxins Testing Using Recombinant Reagents into the United States Pharmacopeia–National Formulary (USP-NF), which has since come into force. This milestone marks the official transition of bacterial endotoxin testing to animal-free reagent platforms, while complying with the 3R principles (Replacement, Reduction, Refinement) in laboratory animal welfare.
Recombinant Cascade Reagent (rCR) delivers a technological breakthrough to replace traditional limulus blood extracts. It safeguards the ecological sustainability of the endangered horseshoe crab, a living fossil with blue hemolymph, and provides an advanced, sustainable solution for pharmaceutical quality control and drug safety assurance.
An Ideal Replacement for Limulus Amebocyte Lysate (LAL)
01 Optimized Three-Factor Cascade Reaction Eliminates G-Factor Pathway Interference
This technology leverages recombinant DNA technology to heterologously express three native proteins from horseshoe crab amebocytes: Factor C, Factor B, and proclotting enzyme. By eliminating the G-factor auxiliary pathway, it eradicates false-positive results triggered by cross-reactivity with 1,3-β-D-glucan, substantially improving the accuracy of endotoxin quantitation.
02 Dynamic Turbidimetric Colorimetric Assay Format Enables Full Compatibility with Existing LAL Testing Infrastructure
rCR retains the dynamic colorimetric assay principle identical to conventional natural LAL. The testing workflow, analytical instruments, software, and consumables are fully interchangeable with standard LAL platforms. Laboratories can reuse existing equipment, implement established staff training protocols, and maintain validated qualification procedures without additional capital investment, enabling seamless migration from native LAL testing workflows.
03 Intact Physiological Cascade Pathway with Native Signal Amplification
✔ Identical catalytic cascade mechanism delivers quantitative equivalence to natural LAL rCR
fully recapitulates the endogenous enzymatic cascade of horseshoe crab lysate, relying on three recombinant proteins to amplify endotoxin-derived signals, ensuring equivalent sensitivity and analytical accuracy to native LAL.
| Test Sample | rCR | Natural LAL | ||
| Endotoxin Level, EU/mL | Spike Recovery (%) | Endotoxin Level, EU/mL | Spike Recovery (%) | |
| Cell culture excipients | <0.005 | 122.6 | <0.005 | 101.70 |
| 300 g/L D-glucose solution | <0.005 | 82.2 | <0.005 | – |
| Fetal Bovine Serum (FBS) | <0.005 | 110.4 | <0.005 | 96.0 |
| Cell culture medium | <0.005 | 114.0 | <0.005 | 123.2 |
| Cell culture supernatant | <0.005 | 95.4 | <0.005 | 152.4 |
| Lyophilized live attenuated Hepatitis A vaccine | <0.005 | 96.6 | <0.005 | 123.6 |
| Monoclonal antibody bulk | 0.026 | 175.4 | 0.034 | 156.6 |
| 0.1% BSA solution | <0.005 | 92.4 | 0.009 | 89.8 |
| Reduced Glutathione for Injection | <1.8 | 100.494 | <1.8 | 105.859 |
| Amikacin Sulfate Injection | <16.5 | 54.947 | <16.5 | 63.928 |
| Nicotinic Acid Injection | <3 | 58.863 | <3 | 61.015 |
| Cefotaxime Sodium API | <2.5 | 61.258 | <2.5 | 71.142 |
| Epinephrine Hydrochloride Injection | <15 | 68.012 | <15 | 67.021 |
Recombinant LAL and natural LAL exhibit equivalent anti-interference performance, and test results from both reagents are interchangeable.
*Only partial validation data are presented
✔ For special samples, recombinant LAL delivers superior anti-interference performance compared with recombinant Factor C (rFC).
Unlike recombinant Factor C (rFC), which consists of a single protein only, recombinant LAL is more resistant to interferences induced by complex matrices when testing special samples. It maintains relatively stable assay performance, enabling more accurate detection of bacterial endotoxins.
| Test Sample | MVD (λ=0.005 EU/mL) | Non-Interfering Dilution (NID) | Spike Recovery (%) | ||
| Recombinant LAL (rCR) | Recombinant Factor C (rFC) | Recombinant LAL (rCR) | Recombinant Factor C (rFC) | ||
| Cell Culture Supplement (Pink) | 100 | 2 | 16 | 122.6 | 79 |
| Emulsifier (Milky White) | 1000 | 40 | 640 | 110.4 | 151.8 |
| Cell Culture Medium (with Phenol Red) | 200 | 1 | 200 | 95.4 | 126.8 |
| Monoclonal Antibody A (High Protein) | 200 | 1 | 2 | 175.4 | 135.4 |
| Normal Saline Injection (High Salt) | 50 | 2 | 16 | 89.6 | 116.8 |
Recombinant LAL (rCR) exhibits superior anti-interference performance at lower dilution folds compared to recombinant Factor C (rFC).
04 Regulatorily Compliant Method Substitution Validation Framework
Major global pharmacopoeial authorities have recognized rCR as a validated alternative to dynamic colorimetric natural LAL. Beyond USP Chapter <86>, the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) accept regulatory submissions supported by fully validated rCR testing workflows.
HZSKBIOⓇ (Huzhou Shenke Biotechnology Co., Ltd.) provides end-to-end regulatory support aligned with international pharmacopoeial standards: from method validation and process implementation to data integrity compliance and global regulatory filing. The company delivers comprehensive technical guidance to design and execute fully compliant substitution validation programs.
PyroSHENTEK® Recombinant Cascade Reagent (rCR)
Catalog No.: 1501112
